Mutation Screening for Deafness
- 1 August 2001
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 127 (8) , 941-942
- https://doi.org/10.1001/archotol.127.8.941
Abstract
THE DISCOVERY that allele variants of GJB2, the gene that encodes the protein connexin 26 (Cx26), cause half of moderate-to-profound nonsyndromic autosomal recessive deafness in many world populations has changed the medical evaluation of the deaf child. The battery of tests that was once routinely ordered, including temporal bone tomography, thyroid function studies, urinalysis, and electrocardiography, can now be replaced with a thorough medical and genetic history, complemented by mutation screening of GJB2. As we prepare to embrace this change, do we, as otolaryngologists, understand the nuances of what is entailed to offer better care to our patients?Keywords
This publication has 7 references indexed in Scilit:
- Pediatric Otolaryngologists' Knowledge and Understanding of Genetic Testing for DeafnessJAMA Otolaryngology–Head & Neck Surgery, 2001
- The M34T Allele Variant of Connexin 26Genetic Testing, 2000
- Parental Attitudes toward Genetic Testing for Pediatric DeafnessAmerican Journal of Human Genetics, 2000
- Autosomal Recessive Nonsyndromic Neurosensory Deafness at DFNB1 Not Associated with the Compound-Heterozygous GJB2 (Connexin 26) Genotype M34T/167delTAmerican Journal of Human Genetics, 2000
- Connexin 26 as a Cause of Hereditary Hearing LossAmerican Journal of Audiology, 1999
- Carrier Rates in the Midwestern United States for GJB2 Mutations Causing Inherited DeafnessJAMA, 1999
- Attitudes of Deaf Adults toward Genetic Testing for Hereditary DeafnessAmerican Journal of Human Genetics, 1998